GENERICS AND BIOSIMILARS INITIATIVE JOURNAL
Official Journal of the Generics and Biosimilars Initiative
Volume 1 / Year 2012 / Issue 2
Perspective
Promoting access to biosimilars: a public−private partnership model for biosimilar development in underserved populations
Author(s): Professor Bryan A Liang, MD, JD, PhD, Timothy Ken Mackey, MAS
Page: 84-8Author byline as per print journal: Timothy Ken Mackey1,2, MAS; Professor Bryan A Liang1,3,4, MD, JD, PhD Abstract: Biologicals represent the future of pharmaceutical treatments and innovation. Yet, emerging and developing markets lack access to these often essential medicines. Biosimilar development represents a potential solution to this problem, by offering lower cost and improved access, but […]
Generic clopidogrel–the medicines agency’s perspective
Author(s): Christoph Baumgärtel, MD, MSc
Page: 89-91Abstract: A number of generic products containing clopidogrel as the active substance have been marketed in Austria and the EU for some time. Due to different clopidogrel salt preparations and different indications, doubts arose as to whether the products could be considered as equivalent. The Austrian Federal Office for Safety in Health Care (BASG)/The Austrian Agency for Health and Food Safety […]
